15,682 Shares in XBiotech Inc (XBIT) Purchased by Virtu Financial LLC

Virtu Financial LLC acquired a new position in shares of XBiotech Inc (NASDAQ:XBIT) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 15,682 shares of the biopharmaceutical company’s stock, valued at approximately $80,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in XBIT. Millennium Management LLC purchased a new stake in XBiotech in the second quarter valued at $931,000. Vanguard Group Inc. raised its position in XBiotech by 5.5% in the third quarter. Vanguard Group Inc. now owns 834,523 shares of the biopharmaceutical company’s stock valued at $2,654,000 after purchasing an additional 43,648 shares during the period. Finally, Vanguard Group Inc raised its position in XBiotech by 5.5% in the third quarter. Vanguard Group Inc now owns 834,523 shares of the biopharmaceutical company’s stock valued at $2,654,000 after purchasing an additional 43,648 shares during the period. 4.29% of the stock is currently owned by institutional investors.

In other XBiotech news, Director W Thorpe Mckenzie bought 24,838 shares of XBiotech stock in a transaction on Monday, December 24th. The shares were bought at an average price of $5.88 per share, for a total transaction of $146,047.44. Following the completion of the transaction, the director now directly owns 3,398,600 shares of the company’s stock, valued at $19,983,768. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders acquired 31,338 shares of company stock worth $174,893 in the last 90 days. Company insiders own 37.00% of the company’s stock.

NASDAQ:XBIT opened at $8.42 on Wednesday. XBiotech Inc has a 52 week low of $2.13 and a 52 week high of $8.90.

Separately, ValuEngine upgraded XBiotech from a “hold” rating to a “buy” rating in a research report on Monday, January 7th.

ILLEGAL ACTIVITY NOTICE: “15,682 Shares in XBiotech Inc (XBIT) Purchased by Virtu Financial LLC” was reported by Enterprise Leader and is the sole property of of Enterprise Leader. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://theenterpriseleader.com/2019/02/06/15682-shares-in-xbiotech-inc-xbit-purchased-by-virtu-financial-llc.html.

About XBiotech

XBiotech Inc, a pre-market biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. The company's lead product is Xilonix, which is also known as MABp1, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer.

See Also: Coverage Ratio

Want to see what other hedge funds are holding XBIT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for XBiotech Inc (NASDAQ:XBIT).

Institutional Ownership by Quarter for XBiotech (NASDAQ:XBIT)

Receive News & Ratings for XBiotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XBiotech and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply